Asia-Pacific Journal of Oncology Nursing

REVIEW ARTICLE
Year
: 2021  |  Volume : 8  |  Issue : 6  |  Page : 596--603

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors


Liyan Zhang1, Yuhan Lu2 
1 Department of GI Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing, China
2 Department of Nursing, Peking University Cancer Hospital and Institute, Beijing, China

Correspondence Address:
Yuhan Lu
Department of Nursing, Peking University Cancer Hospital and Institute, Beijing
China

The rapid advances in cancer immunotherapy using immune checkpoint inhibitors (ICIs) have led to significantly improved survival of patients. But at the same time, it also associates with multiple immune-related adverse events (irAEs). The irAEs can affect a wide range of organs, and induce nonspecific symptoms with delayed onset and prolonged duration that is easily neglected, which may lead to life-threatening disorders. Therefore, follow-up care for patients receiving ICIs for irAEs management has become an essential competency in cancer nursing. There are several guidelines about the management of irAEs, which focused on diagnosis, grading, and treatment. However, studies on relevant follow-up care are rare. Nurses play an important role in follow-up care, whose relevant knowledge and skills are indispensable. Combined with domestic and foreign guidelines and related studies, this paper reviewed the occurrence and characteristics of irAEs and highlighted the contents, timing, models, and effects of follow-up care for patients receiving ICIs, to provide a reference for clinical nursing practice and improve the safety of immunotherapy for patients.


How to cite this article:
Zhang L, Lu Y. Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors.Asia Pac J Oncol Nurs 2021;8:596-603


How to cite this URL:
Zhang L, Lu Y. Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors. Asia Pac J Oncol Nurs [serial online] 2021 [cited 2021 Nov 29 ];8:596-603
Available from: https://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=6;spage=596;epage=603;aulast=Zhang;type=0